Showing results (61-70 of 168) with videos related to
Sort By:
Pageof 17
The Journal of Physiology|August 27, 2003
Activation-dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated currentLawrence N Eisenman, Yejun He, Christopher Fields, et al.Proceedings of the National Academy of Sciences of the United States of America|November 4, 2021
Cognitive deficits and impaired hippocampal long-term potentiation in KATP-induced DEND syndromeShaul Yahil, David F Wozniak, Zihan Yan, et al.Proceedings of the National Academy of Sciences of the United States of America|July 24, 2024
GABAA receptor subunit composition regulates circadian rhythms in rest-wake and synchrony among cells in the suprachiasmatic nucleusDaniel Granados-Fuentes, Peter Lambert, Tatiana Simon, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Current practices by Alzheimer's Disease Research Centers to remunerate research participantsMatthew Gabel, Semere Bekena, Mitch O'Meara, et al.Trends in Neurosciences|April 23, 2010
The sticky issue of neurosteroids and GABA(A) receptorsMariangela Chisari, Lawrence N Eisenman, Douglas F Covey, et al.Molecular Pharmacology|January 16, 2016
Comparison of Steroid Modulation of Spontaneous Inhibitory Postsynaptic Currents in Cultured Hippocampal Neurons and Steady-State Single-Channel Currents from Heterologously Expressed α1β2γ2L GABA(A) ReceptorsSampurna Chakrabarti, Mingxing Qian, Kathiresan Krishnan, et al.Journal of Neurophysiology|June 5, 2015
Quantification of bursting and synchrony in cultured hippocampal neuronsLawrence N Eisenman, Christine M Emnett, Jayaram Mohan, et al.Neuroscience and Biobehavioral Reviews|October 23, 2012
Neurosteroids, stress and depression: potential therapeutic opportunitiesCharles F Zorumski, Steven M Paul, Yukitoshi Izumi, et al.Alzheimer'S & Dementia (New York, N. Y.)|February 14, 2025
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer's diseaseSarah M Hartz, Suzanne E Schindler, Marissa L Streitz, et al.Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer diseaseSarah M Hartz, Suzanne E Schindler, Marissa L Streitz, et al.Pageof 17